Aleksandar Sekulic was named physician-in-chief at the Translational Genomics Research Institute, part of City of Hope.
The Stephenson Global Pancreatic Cancer Research Institute is creating new awards to advance pancreatic cancer research.
Earlier this week at City of Hope, we celebrated World Cancer Day by announcing ambitious solutions to tackle some of the most pressing challenges in cancer care. This includes groundbreaking advancements in microbiome research aimed at improving cancer survival, increased emphasis on cancers that disproportionately affect women and people of color, and enhanced access to advanced cancer treatment.
Walter M. Stadler was appointed as the chief clinical officer at City of Hope Cancer Center Chicago.
Advances such as new nontoxic, more effective immunotherapy and improvements that significantly reduce recovery times for complicated surgeries are making cancer treatments less taxing. On the horizon are more ways to give patients the greatest chance of survival while also reducing negative consequences of treatment. Some therapies also will improve the experience, such as chemotherapy consisting of quick subcutaneous injections instead of hours in an infusion chair.
I am pleased to begin a new series from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. With our National Medical Center ranking among the top 5 for cancer by U.S. News & World Report, we are making a profound and lifesaving difference.
Last week, The Cancer Letter interviewed City of Hope physician Ravi Salgia, who evacuated from his Eaton Canyon home with his wife on the evening of Jan. 7 due to approaching wildfires driven by the Santa Ana winds.
The Translational Genomics Research Institute, part of City of Hope, has announced the appointment of John D. Fryer as a professor in the Division of Bioinnovation and Genome Sciences and director of the newly established Center for Accelerated Nanotherapeutics.
Scientists at City of Hope identified a protein that could help prevent CAR T-cell therapy antigen escape. The research, published in the journal Cell, could lead to more personalized therapies that improve cancer patients’ survival.
On Jan. 7, a bit after 6 p.m., Ravi Salgia was at his Eaton Canyon home, at the edge of Angeles National Forest.
